SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD

Review checklist: Hubert H. Humphrey (HR-ML022)
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
- 11judgment calls in the dossier
- 1protocol deviations
- 0orders and referrals without results in the record
- 0evidence items to check (retrospective or sensitive claims, unconfirmed diagnoses)
Review status
| Review | Status | Reviewer | Date | Notes |
|---|
| schema validation | not_started | | | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | | | Awaiting clinician review; check the pathway from recurrent high-risk non-muscle-invasive disease after radiation to early cystectomy, the omission of adjuvant therapy for pT2a N0, the surveillance intervals, and the infection management with a conduit. |
| provenance review | not_started | | | Historical facts from TIME (1976 and 1977), an Associated Press report (1994), the Senate biography, and a reference encyclopedia. No statement or health fact is attributed to a relative or to a named physician. Tobacco history is not recorded because no reliable source was found. |
| safe messaging review | not_started | | | The record is clinical and contains no political content; the later recurrence and death are recorded as history without detail. |
Judgment calls (dossier editorial resolutions)
- Recent-death rule. Humphrey died in 1978, so the recent-death rule does not apply. The record still attributes no statement or health fact to a relative or to a named physician: the surgeon’s and the spouse’s remarks quoted in the TIME reports are not used, and an oral history by another public figure that dates the operation to a specific day is not used.
- Clinical, not political. The record is clinical. His public career appears only in the timeline and as a synthetic occupation (“a demanding public job”). The political content of the 1977 TIME report is not used.
- Tobacco. No reliable source was found for his tobacco use; a trivia page that calls him a heavy smoker was not used. The record states only that he reports no current use and that his past history is not recorded, and lung cancer and aortic aneurysm screening are recorded as due, pending that history. A reviewer may want to source this or leave it as is.
- Index age and dates. The modern episode presents Humphrey at 65, three months after his radical cystoprostatectomy. The synthetic date of birth is May 27, 1960 (shift 49 years). The resection on September 2, the staging CT on September 16, and the cystoprostatectomy on October 7, 2025 map to September and October 1976; the documented month of the operation is October 1976, and the day is synthetic. The index visit on January 6, 2026 maps to January 6, 1977, the week he resumed his Senate duties, which fits the synthetic note that he is back at full-time work. The chronic-care visits on February 3, April 7, and July 7, the sick visit on March 17, and the annual wellness visit on June 2, 2026 map to the same days of 1977. All visits fall before August 1977, when the inoperable pelvic recurrence was found. He turns 66 on May 27, so the wellness visit is at 66 and is `annual_wellness_subsequent` (index age 65).
- Documented course and the synthetic pathway. The documented history (benign growths, then thiotepa and X-ray therapy, three years free of cancer, a low-grade malignancy, and then radical cystectomy with a small-intestine conduit) is used in the past medical history and the referral. The modern pathway is chosen to fit: recurrent multifocal low-grade papillary tumors with high-grade carcinoma in situ in a small, irradiated bladder, which in current practice supports early cystectomy, with upstaging to pT2a at cystectomy, 0 of 18 nodes, and negative margins. The grade, stage, node count, and margins are synthetic; the node result was not reported in the fetched sources. No adjuvant therapy is given, which current guidelines support for pT2a N0. TIME reported that an experimental two-drug chemotherapy might be offered after the operation; whether he received treatment before August 1977 was not found in a fetched source, and the record makes no claim about it.
- Later recurrence. His pelvic recurrence ten months after the operation is documented and is recorded as a claim and in the timeline, but the synthetic episode ends before it. To avoid a synthetic result that would read against the documented course, the episode contains no post-operative cross-sectional imaging: the first surveillance CT is recorded as due at one year after surgery, which is within the 6-to-12-month interval the guideline allows for pT2 N0 disease. The six-month renal ultrasound looks only for hydronephrosis. Reviewers may prefer to shorten the CT interval to six months, but that would place a synthetic negative scan about four months before the documented recurrence.
- Sick visit. The unscheduled visit on March 17, 2026 (true frame March 17, 1977) is a synthetic acute right pyelonephritis with Escherichia coli and mild acute kidney injury, treated with seven days of oral ciprofloxacin. It was chosen because upper-tract infection is a common complication of an ileal conduit, and because it teaches the difference between expected bacteriuria in conduit urine and a true infection, with a culture taken by catheter through the stoma. TIME reports urinary tract infection symptoms before the 1976 diagnosis; the synthetic infection is after the operation and does not echo a documented illness.
- Annual wellness visit. Judgment calls: (1) the synthetic AUDIT-C of 2 (an occasional social drink) is not drawn from a source; (2) a statin was discussed at about 14 percent ten-year risk as a current non-smoker, with no additional USPSTF risk factor, and he chose to revisit it; (3) colonoscopy four years earlier and a negative hepatitis C screen are synthetic history; (4) advance care planning names an unnamed health care agent and records only general priorities; (5) erectile dysfunction after cystoprostatectomy is recorded plainly as an expected effect of the operation, with no treatment wanted.
- Focused visits. The three chronic-care follow-ups (four weeks, three months, and six months after the first visit, that is four, six, and nine months after surgery) are documented as focused visits on the AUA/ASCO/SUO muscle-invasive guideline and the CMID urologic cancer monograph. Each lists every item the protocol calls for at that point, with its interval and status. The first is the same day as the urology consultation. One protocol deviation is recorded instead of an invented result: the creatinine recheck planned one week after the sick visit was not done. At the next visit, creatinine was 1.15 mg/dL, near the baseline of 1.12, so no harm is judged to have resulted; rechecks are now booked before he leaves the clinic. Synthetic findings introduced: appliance leaks with irritant peristomal dermatitis from a skin crease, corrected with a convex wafer; mild hyperchloremic metabolic acidosis (bicarbonate 20 mmol/L) treated with sodium bicarbonate and corrected to 24 mmol/L. Routine urine cultures, urethral wash cytology, and adjuvant therapy are recorded as not indicated, with the reason.
- Consultation. The urology referral and the consultation by Elaine Kowalczyk, MD (a fictional consultant), with a wound, ostomy, and continence nurse, on the day of the first focused visit, are S. The consultant answers the six referral questions with what the record shows happened afterwards: no adjuvant therapy; CT with a urographic phase at one year and then every 6 to 12 months; a renal ultrasound at six months; chemistry every 3 to 6 months with sodium bicarbonate for a bicarbonate below 22 mmol/L; a convex wafer and night drainage; no treatment of bacteriuria without symptoms and a catheter culture through the stoma for fever or flank pain; and no routine urethral cytology. The examination is consistent with Dr. Brandvold’s same-day note.
- Not used. The day of the operation given in an oral history, a 1974 hospital admission for tests reported in the Chicago Tribune (not fetched), the p53 study beyond its title, the details of his final months, and a search summary that suggested his cancer had returned by the end of 1976 (no fetched source said so) are not used. His height is not recorded in a fetched source; the 180 cm in the record is synthetic.
Protocol deviations
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|
2026-04-07 Progress note 04 (C-CDA) | Creatinine one week after acute kidney injury | One week after the sick visit | Not done, a deviation from the plan made at the sick visit; he was travelling. Today's creatinine of 1.15 mg/dL is near the baseline of 1.12, so the kidney injury resolved and no harm resulted. Corrective action: post-illness rechecks are now booked before he leaves the clinic, with a reminder call |
Orders and referrals without results in the record
None.
Evidence to check
Retrospective claims (R)
None.
Sensitive claims
None.
Diagnoses not confirmed
None.
Notes to read
Every note in the record, with its type. All clinical content is synthetic.
Abnormal results
| Date | Result | Value | Flag |
|---|
| 2026-01-06 | Hemoglobin | 12.6 g/dL (low) | Low |
| 2026-04-07 | Chloride | 110 mmol/L (high) | High |
| 2026-04-07 | Bicarbonate (total CO2) | 20 mmol/L (low) | Low |
| 2026-03-17 | White cell count | 12.6 10*3/uL (high) | High |
| 2026-03-17 | Bicarbonate (total CO2) | 20 mmol/L (low) | Low |
| 2026-03-17 | Urea nitrogen | 26 mg/dL (high) | High |
| 2026-03-17 | Creatinine | 1.41 mg/dL (high) | High |
| 2026-03-17 | eGFR | 55 mL/min/1.73 m² (low) | Low |
| 2026-03-17 | Urine white cells (catheterized stoma specimen) | 55 /[HPF] (high) | High |
| 2026-03-17 | Urine culture colony count (catheterized stoma specimen; final report two days later: Escherichia coli, susceptible to ciprofloxacin) | 100000 {CFU}/mL (high) | High |